Helena Beer

Helena Beer focuses on how new clinical evidence, hospital service models and policy decisions translate into practice for senior secondary care clinicians, with a particular emphasis on cardiovascular risk and cross-specialty quality improvement. She is editor of Hospital Healthcare Europe and Hospital Pharmacy Europe, overseeing writing, commissioning and editing for consultant and senior stakeholder audiences while continuing to report herself on practice-changing studies, consensus statements and case studies. Her work combines concise news writing with an editor’s eye for best practice, highlighting innovative ideas for tackling healthcare challenges and delivering more efficient, effective patient care.

Tackling cardiovascular risks of UPF

Helena Beer uses major cardiovascular consensus statements and trials as anchors to explore evolving risk and prevention strategies for hospital clinicians. Her coverage of an European Society of Cardiology clinical consensus statement on the cardiovascular risks of ultra-processed foods sets out how lifestyle factors are being integrated into contemporary prevention guidance and what that means for patient counselling and service planning. She co-authors in-depth pieces on the importance of vaccines in cardiovascular prevention, drawing out key messages from ESC leadership on informing cardiac patients and addressing vaccine misinformation to support care for those at heightened risk of major events.

In her reporting on retatrutide, she unpacks a phase 3 trial in which a triple hormone receptor agonist delivers weight-loss outcomes comparable to bariatric surgery, detailing dose regimens, trial duration and percentage weight reductions across treatment arms.

She also follows the intersection of mental health and heart disease, summarising meta-analytic evidence that depressive disorders, anxiety disorders, post-traumatic stress disorder and sleep disorders are associated with increased risk of acute coronary syndrome and acute myocardial infarction. Across these pieces, she keeps the focus on practical risk stratification and prevention strategies that hospital teams can apply, rather than abstract cardiology theory.

Leicester’s AF virtual ward expansion: from pilot project to national rollout

Service redesign and virtual care models are a recurring strand in Helena Beer’s coverage, treated as detailed case studies for clinicians and managers. Her article on a pioneering atrial fibrillation virtual ward describes its progression from pilot project to expanded service with the potential to prevent thousands of hospital admissions each year, emphasising patient selection, multidisciplinary collaboration and measured impact on admission avoidance.

She uses this story to show how digital infrastructure and clinical protocols can be combined to manage high-risk cardiovascular patients outside traditional inpatient pathways. Similar service-level reporting examines AI-powered administrative support, where she sets out trial findings that estimate time savings of tens of minutes per day for healthcare staff and frame the opportunity to reinvest those hours into direct patient care.

In these pieces she balances frontline accounts with quantified outcomes, making organisational change stories immediately usable for senior clinical and managerial audiences responsible for redesigning hospital pathways.

Burden of mental health disorders in people with vitiligo revealed in large cohort study

Helena Beer regularly distils new cohort studies and trials across dermatology, oncology, gastroenterology and other specialties, always foregrounding patient impact and clinical decision-making. Her article on the burden of mental health disorders in people with vitiligo reports substantial levels of mood- and stress-related conditions in this group, positioning the findings within a wider conversation about psychosocial dermatology and holistic care.

In dermatology, she assesses the effectiveness of population skin cancer screening programmes, explaining long-term melanoma mortality trends and subgroup analyses that show no statistically significant mortality benefit compared with neighbouring countries without such screening.

She covers AI-supported mammography screening by translating performance metrics - sensitivity, interval cancers and specificity - into plain statements about non-inferiority and potential improvements in early detection. Her reporting on appendicitis, psoriasis and eczema likewise turns statistical results into clear guidance: long-term durability and safety of antibiotic therapy for uncomplicated appendicitis, differences in drug survival among biologics to guide psoriasis treatment selection, and evidence that bathing frequency does not worsen eczema symptoms.

Across this cross-specialism work, she consistently connects study design and numerical outcomes to what changes at the bedside or clinic door.

How and why clinicians should embrace sustainability and Trust green plans

Beyond clinical endpoints, Helena Beer writes about sustainability, workforce pressures and technology adoption as integral parts of hospital practice.

In her piece on refreshed green plans, she presents advice from a hospital sustainability team on practical steps clinicians can take to contribute to organisational environmental goals while maintaining service quality, framing sustainability as a professional responsibility rather than a peripheral concern. She reports on AI tools in radiology and administration by combining technical performance data with everyday efficiency gains, showing how innovations such as AI-supported mammography and administrative copilots can reduce interval cancers, cut routine workloads and free clinicians to focus more on direct patient care.

Several of her articles examine vulnerable patient groups and gaps in current pathways, including RSV protection for premature babies, the long-term risk of breast cancer death when initial screening is missed and the cardiovascular effects of Covid-19 and long Covid described in ESC consensus work. As editor, she also oversees content partnerships, roundtable reports, handbooks and virtual events that showcase expert commentary and best-practice case studies across core secondary care specialisms such as cardiovascular, dermatology, gastroenterology, oncology, respiratory and rheumatology.

Helena Beer’s editorial approach is shaped by a long career in healthcare trade journalism and editing.

Before taking on her current role, she spent many years working as a writer and editor in the community pharmacy trade press, as well as editing a publication focused on pharmaceutical marketing and medical affairs, which informs her interest in professional developments and cross-sector collaboration between hospitals, pharmacy and industry. She has also freelanced for a range of national consumer magazines, bringing a concise, accessible style to articles aimed at a technically sophisticated clinical audience.

Membership of a medical journalists’ association underlines her focus on accuracy, ethical reporting and maintaining trust with specialist readers who rely on clear, evidence-based coverage to support their practice.